Peiwei Yang
Wuhu, 241002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
From cellular therapy to biologics: non-viral delivery strategies for in vivo CAR-T engineering.
Journal: Critical reviews in oncology/hematology
Published: August 07, 2026
Engineering viral vectors for in vivo CAR-T generation: Advances, challenges, and opportunities.
Journal: Critical reviews in oncology/hematology
Published: January 12, 2026
CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy.
Journal: Journal for immunotherapy of cancer
Published: November 11, 2024
CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: November 29, 2022
Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice.
Journal: Cell death & disease
Published: August 22, 2021
Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes.
Journal: Signal transduction and targeted therapy
Published: August 08, 2021
Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas.
Journal: Cell death & disease
Published: April 29, 2020
Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12.
Journal: Cancer medicine
Published: March 02, 2019
Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy.
Journal: Journal of hematology & oncology
Published: May 22, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026